NeoPred: dual-phase CT AI forecasts pathologic response to neoadjuvant chemo-immunotherapy in NSCLC

Background Accurate preoperative prediction of major pathological response or pathological complete response after neoadjuvant chemo-immunotherapy remains a critical unmet need in resectable non-small-cell lung cancer (NSCLC). Conventional size-based imaging criteria offer limited reliability, while...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Journal for ImmunoTherapy of Cancer
المؤلفون الرئيسيون: Rui Wang, Guan Wang, Ying Huang, Yu Jiang, Zhigang Li, Chao Yang, Yuan Zhang, Hengrui Liang, Jianxing He, Zhichao Liu, Hongxu Liu, Jia Zhang, Hong Yu, Guangjian Zhang, Hongshen Deng, Zeping Yan, Wenhai Fu, Jianqi Zheng, Runchen Wang, Houlu Xiao, Zhenlin Chen, Xiaomin Ge, Pingwen Yu, Junke Fu, Bohao Liu, Chudong Wang, Yuechun Lin, Linchong Huang, Fei Cui
التنسيق: مقال
اللغة:الإنجليزية
منشور في: BMJ Publishing Group 2025-05-01
الوصول للمادة أونلاين:https://jitc.bmj.com/content/13/5/e011773.full